Ayvakit for Gastrointestinal Stromal Tumors Approved in China
source: pixabay.com

Ayvakit for Gastrointestinal Stromal Tumors Approved in China

According to a story from Markets Insider, the biopharmaceutical company CStone Pharmaceuticals has announced that China's National Medical Products Administration (NMPA) has approved avapritinib (marketed as Ayvakit) as a treatment…

Continue Reading Ayvakit for Gastrointestinal Stromal Tumors Approved in China
The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children
source: pixabay.com

The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children

  Cancer Network recently reported that Jazz Pharmaceuticals’ Vyxeos was approved by the FDA to treat therapy-related pediatric patients one year or older who were newly diagnosed with acute myeloid…

Continue Reading The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children
Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research
source: pixabay.com

Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research

Financial Burdens in Rare Disease In 2019, 20% of all adults in the United States have reported that they had large medical bills that were unexpected. 18% currently had medical…

Continue Reading Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research
FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month
source: pixabay.com

FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month

By May 25th, 2021 the FDA will announce their decision regarding approval of Opdivo used in combination with chemotherapy for gastrointestinal cancers. Back in December, Priority Review was granted to…

Continue Reading FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month
A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe
source: pixabay.com

A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe

Aeglea Biotherapeutics has just announced a new collaboration with Immedica to bring pegzilarginase to other countries outside of the United States. They have created a license and supply agreement to…

Continue Reading A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe